On Monday, Protara Therapeutics Inc (NASDAQ: TARA) was -3.36% drop from the session before settling in for the closing price of $2.98. A 52-week range for TARA has been $1.60 – $10.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 55.31% over the last five years. When this article was written, the company’s average yearly earnings per share was at 30.99%. With a float of $34.42 million, this company’s outstanding shares have now reached $38.58 million.
The firm has a total of 33 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Protara Therapeutics Inc (TARA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Protara Therapeutics Inc stocks. The insider ownership of Protara Therapeutics Inc is 10.78%, while institutional ownership is 69.41%. The most recent insider transaction that took place on May 14 ’25, was worth 63,800. In this transaction Director of this company bought 20,000 shares at a rate of $3.19, taking the stock ownership to the 51,000 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Chf Scientific Operations Off sold 21,224 for $4.53, making the entire transaction worth $96,145. This insider now owns 98,861 shares in total.
Protara Therapeutics Inc (TARA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 30.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.28% during the next five years compared to 55.31% growth over the previous five years of trading.
Protara Therapeutics Inc (NASDAQ: TARA) Trading Performance Indicators
You can see what Protara Therapeutics Inc (TARA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 18.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.73, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.71 in one year’s time.
Technical Analysis of Protara Therapeutics Inc (TARA)
Analysing the last 5-days average volume posted by the [Protara Therapeutics Inc, TARA], we can find that recorded value of 1.12 million was better than the volume posted last year of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 12.86%.
During the past 100 days, Protara Therapeutics Inc’s (TARA) raw stochastic average was set at 1.24%, which indicates a significant decrease from 4.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.49% in the past 14 days, which was lower than the 76.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.34, while its 200-day Moving Average is $3.57. Now, the first resistance to watch is $3.00. This is followed by the second major resistance level at $3.13. The third major resistance level sits at $3.20. If the price goes on to break the first support level at $2.80, it is likely to go to the next support level at $2.73. Now, if the price goes above the second support level, the third support stands at $2.60.
Protara Therapeutics Inc (NASDAQ: TARA) Key Stats
There are 38,582K outstanding shares of the company, which has a market capitalization of 111.12 million. As of now, sales total 0 K while income totals -44,600 K. Its latest quarter income was 0 K while its last quarter net income were -11,910 K.
